ifosfamide has been researched along with Mixed Tumor, Mullerian in 10 studies
Mixed Tumor, Mullerian: A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. (Holland et al., Cancer Medicine, 3d ed, p1703)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between 1992 and 1999, 13 consecutive patients with completely resected moderate- to high-grade uterine sarcoma received three cycles of adjuvant ifosfamide (1." | 7.70 | Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma. ( Belinson, JL; Kennedy, AW; Kushner, DM; Markman, M; Rybicki, LA; Webster, KD, 2000) |
| "Four patients with metastatic ovarian mixed Müllerian sarcoma (2 homologous, 2 heterologous) were treated with mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy." | 7.69 | Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases. ( Greenberg, S; Patsner, B, 1995) |
| "Between 1992 and 1999, 13 consecutive patients with completely resected moderate- to high-grade uterine sarcoma received three cycles of adjuvant ifosfamide (1." | 3.70 | Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma. ( Belinson, JL; Kennedy, AW; Kushner, DM; Markman, M; Rybicki, LA; Webster, KD, 2000) |
| "Four patients with metastatic ovarian mixed Müllerian sarcoma (2 homologous, 2 heterologous) were treated with mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy." | 3.69 | Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases. ( Greenberg, S; Patsner, B, 1995) |
| "Ovarian cancer was suspected, so the patient underwent exploratory laparotomy." | 1.36 | Primary malignant mixed müllerian tumor of the ovary. ( Chao, KC; Chiu, SY; Lai, CH; Twu, NF; Yen, MS, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, SY | 1 |
| Twu, NF | 1 |
| Lai, CH | 1 |
| Yen, MS | 1 |
| Chao, KC | 1 |
| Patrelli, TS | 1 |
| Gizzo, S | 1 |
| Di Gangi, S | 1 |
| Guidi, G | 1 |
| Rondinelli, M | 1 |
| Nardelli, GB | 1 |
| Kosmas, C | 1 |
| Vorgias, G | 1 |
| Tsakonas, G | 1 |
| Politis, P | 1 |
| Daladimos, T | 1 |
| Panagiotidi, E | 1 |
| Papachrysanthou, T | 1 |
| Moschovis, D | 1 |
| Kalinoglou, N | 1 |
| Tsavaris, N | 1 |
| Karabelis, A | 1 |
| Mylonakis, N | 1 |
| Ramondetta, LM | 1 |
| Burke, TW | 1 |
| Jhingran, A | 1 |
| Schmandt, R | 1 |
| Bevers, MW | 1 |
| Wolf, JK | 1 |
| Levenback, CF | 1 |
| Broaddus, R | 1 |
| Dusenbery, KE | 1 |
| Potish, RA | 1 |
| Argenta, PA | 1 |
| Judson, PL | 1 |
| Ruiz Tovar, J | 1 |
| Reguero Callejas, ME | 1 |
| Arano Bermejo, JI | 1 |
| Capote Armas, LF | 1 |
| González-Palacios Martínez, F | 1 |
| Cabañas Navarro, L | 1 |
| Patsner, B | 1 |
| Greenberg, S | 1 |
| Di Vagno, G | 1 |
| Cormio, G | 1 |
| Loverro, G | 1 |
| Melilli, GA | 1 |
| Di Gesù, G | 1 |
| Selvaggi, L | 1 |
| Kushner, DM | 1 |
| Webster, KD | 1 |
| Belinson, JL | 1 |
| Rybicki, LA | 1 |
| Kennedy, AW | 1 |
| Markman, M | 1 |
| Sit, AS | 1 |
| Price, FV | 1 |
| Kelley, JL | 1 |
| Comerci, JT | 1 |
| Kunschner, AJ | 1 |
| Kanbour-Shakir, A | 1 |
| Edwards, RP | 1 |
2 reviews available for ifosfamide and Mixed Tumor, Mullerian
| Article | Year |
|---|---|
Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature.
Topics: Adenosarcoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Chemotherapy, Adju | 2011 |
On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Brachytherapy; Chemotherapy, Adjuvant; Combined Modality | 2005 |
1 trial available for ifosfamide and Mixed Tumor, Mullerian
| Article | Year |
|---|---|
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Ifosfamide; | 2003 |
7 other studies available for ifosfamide and Mixed Tumor, Mullerian
| Article | Year |
|---|---|
Primary malignant mixed müllerian tumor of the ovary.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Ifosfamide; Middle Aged; M | 2010 |
Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours.
Topics: Adnexal Diseases; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplat | 2011 |
Malignant mixed Mullerian tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemo | 2006 |
Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Combined Modality Therapy; Da | 1995 |
Prolonged survival of stage IV malignant mixed Müllerian tumor of the ovary after carboplatin, mesna, ifosfamide, and cis-platin chemotherapy: case report.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality T | 1998 |
Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; | 2000 |
Chemotherapy for malignant mixed Müllerian tumors of the ovary.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; H | 2000 |